Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity
F Imperi, F Massai, M Facchini… - Proceedings of the …, 2013 - National Acad Sciences
Although antibiotic resistance represents a public health emergency, the pipeline of new
antibiotics is running dry. Repurposing of old drugs for new clinical applications is an …
antibiotics is running dry. Repurposing of old drugs for new clinical applications is an …
[HTML][HTML] Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity
F Imperi, F Massai, M Facchini… - Proceedings of the …, 2013 - ncbi.nlm.nih.gov
Although antibiotic resistance represents a public health emergency, the pipeline of new
antibiotics is running dry. Repurposing of old drugs for new clinical applications is an …
antibiotics is running dry. Repurposing of old drugs for new clinical applications is an …
[引用][C] Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity
F Imperi, F Massai, M Facchini, E Frangipani… - … OF THE NATIONAL …, 2013 - ora.uniurb.it
Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa
pathogenicity IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT …
pathogenicity IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT …
Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity.
F Imperi, F Massai, M Facchini… - Proceedings of the …, 2013 - europepmc.org
Although antibiotic resistance represents a public health emergency, the pipeline of new
antibiotics is running dry. Repurposing of old drugs for new clinical applications is an …
antibiotics is running dry. Repurposing of old drugs for new clinical applications is an …
[PDF][PDF] Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity
F Imperia, F Massaib, M Facchinic, E Frangipanib… - researchgate.net
Although antibiotic resistance represents a public health emergency, the pipeline of new
antibiotics is running dry. Repurposing of old drugs for new clinical applications is an …
antibiotics is running dry. Repurposing of old drugs for new clinical applications is an …
[PDF][PDF] Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity
F Imperia, F Massaib, M Facchinic, E Frangipanib… - academia.edu
Although antibiotic resistance represents a public health emergency, the pipeline of new
antibiotics is running dry. Repurposing of old drugs for new clinical applications is an …
antibiotics is running dry. Repurposing of old drugs for new clinical applications is an …
Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity
F Imperi, F Massai, M Facchini, E Frangipani… - … OF THE NATIONAL …, 2013 - iris.uniroma1.it
Although antibiotic resistance represents a public health emergency, the pipeline of new
antibiotics is running dry. Repurposing of old drugs for new clinical applications is an …
antibiotics is running dry. Repurposing of old drugs for new clinical applications is an …
Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity
F Imperi, F Massai, M Facchini, E Frangipani… - Proceedings of the …, 2013 - JSTOR
Although antibiotic resistance represents a public health emergency, the pipeline of new
antibiotics is running dry. Repurposing of old drugs for new clinical applications is an …
antibiotics is running dry. Repurposing of old drugs for new clinical applications is an …
[PDF][PDF] Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity
F Imperia, F Massaib, M Facchinic, E Frangipanib… - sys.91sqs.net
Although antibiotic resistance represents a public health emergency, the pipeline of new
antibiotics is running dry. Repurposing of old drugs for new clinical applications is an …
antibiotics is running dry. Repurposing of old drugs for new clinical applications is an …
Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity
F Imperi, F Massai, M Facchini, E Frangipani… - Proceedings of the …, 2013 - cir.nii.ac.jp
抄録< jats: p> Although antibiotic resistance represents a public health emergency, the
pipeline of new antibiotics is running dry. Repurposing of old drugs for new clinical …
pipeline of new antibiotics is running dry. Repurposing of old drugs for new clinical …